# Luteolin for the Treatment of People With Schizophrenia

> **NCT05204407** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 85 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Luteolin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05204407
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-13
- **Primary completion:** 2026-01-14
- **Final completion:** 2026-01-14
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05204407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05204407, "Luteolin for the Treatment of People With Schizophrenia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05204407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*